Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced preliminary fourth quarter and full year 2025 net product revenue ...
Explore the pros and cons of passwordless authentication for b2b tech. Learn how mfa and ciam shifts impact security and user experience.
Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately $75 million for the full year of 2025Autolus anticipat ...
Concepts NREC introduces Agile Engineering Design System v2025.2 with advanced volute modeling, secondary flow capabilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback